Aidapak Recalls Calcium Carbonate Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling Calcium Carbonate/Cholecalciferol tablets because they may be mislabeled as Repaglinide. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported injuries or illnesses, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling Calcium Carbonate/Cholecalciferol, Tablet, 600 mg/800 units, Over The Counter, NDC 00005550924. The recall is due to a labeling error where the product may be potentially mis-labeled as Repaglinide, Tablet, 1 mg, NDC 00169008281.
The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. The specific product codes are Pedigree: AD52993_1 and EXP: 5/17/2014. The quantity per package is 120 Tablets.
Consumers should check their medication labels to ensure they are not taking the mislabeled product. If the label indicates Repaglinide but the product is actually Calcium Carbonate/Cholecalciferol, or vice versa, consumers should stop using the product and contact their healthcare provider or the recalling firm for instructions.
The recalled product
- Product
- CALCIUM CARBONATE/CHOLECALCIFEROL, Tablet, 600 mg/800 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00005550924.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-The-Counter
- Hazard
- Affected units
- 120
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- CALCIUM CARBONATE/CHOLECALCIFEROL
- Tablet
- 600 mg/800 units has the following codes: Pedigree: AD52993_1
- EXP: 5/17/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Cholecalciferol Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Cholecalciferol Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Cholecalciferol Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Cholecalciferol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Calcium Carbonate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateFDA Recalls Calcium Citrate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22